KALARIS THERAPEUTICS, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
KALARIS THERAPEUTICS, INC. (KLRS) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 2.54 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-11
- KALARIS THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 2.85M shares, a 148.23% increase year-over-year.
- KALARIS THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 1.15M shares, a 88.15% decline year-over-year.
- KALARIS THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 9.67M shares.
- KALARIS THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 2.14M shares, a 83.78% decline from fiscal 2024.
- KALARIS THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 13.21M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|
| 2026-06-30 | 2.54M shares 10-Q · filed 2026-08-11 | |||
| 2026-03-31 | 2.85M shares 10-Q · filed 2026-05-12 | |||
| 2025-12-31 | 2.14M shares 10-K · filed 2026-03-17 | |||
| 2025-09-30 | 2.09M shares 10-Q · filed 2025-11-12 | |||
| 2025-06-30 | 1.99M shares 10-Q · filed 2026-08-11 | |||
| 2025-03-31 | 1.15M shares 10-Q · filed 2026-05-12 | |||
| 2024-12-31 | 13.21M shares 10-K · filed 2026-03-17 | |||
| 2024-09-30 | 11.53M shares 10-Q · filed 2025-11-12 | |||
| 2024-06-30 | 11.48M shares 10-Q · filed 2025-08-13 | |||
| 2024-03-31 | 9.67M shares 10-Q · filed 2025-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |